MedTrace Logo

Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)

NCT05865054 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-09-19

No results posted yet for this study

Summary

The research study is being conducted to determine the utility of magnetic resonance imaging (MRI) in identifying inflammation of arteries supplying blood to the head, brain, and eyes. The target population includes patient with suspected giant cell arteritis (GCA; temporal arteritis).

Conditions

  • Giant Cell Arteritis

Interventions

DIAGNOSTIC_TEST

Magnetic Resonance Imaging (MRI)

Combined orbital and cranial vessel wall MRI

Sponsors & Collaborators

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • Rennie Rhee, MD · University of Pennsylvania

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-29
Primary Completion
2030-07-31
Completion
2033-07-31

Countries

  • United States
  • Canada
  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05865054 on ClinicalTrials.gov